ArticleBMC oral health2024
Cross-cultural adaptation of the Turkish version of the dentin hypersensitivity experience questionnaire short form (DHEQ-15).
Article in BMC oral health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Home-use agents in the treatment of dentin hypersensitivity: clinical effectiveness evaluation with different measurement methods.Clinical oral investigations · 2025Trial
- Exploring the Impact of Dentine Hypersensitivity: Validation of the Spanish DHEQ-15 and Its Cultural Adaptation.Journal of clinical and experimental dentistry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe short form of the Dentin Hypersensitivity Experience Questionnaire (DHEQ-15) is a valid and reliable tool for Oral Health-Related Quality of Life (OHRQoL) studies. The aim of this study was cross-culturally adapt and validate the English version of DHEQ-15 for the Turkish language.
methodsThe Turkish version of the DHEQ-15 was developed using the forward-backward translation method. Two independent translators translated it from English to Turkish, followed by back-translation into English. A pilot study was conducted with 30 patients with dentin hypersensitivity (DH). The sample consisted of 150 individuals with DH and 150 without. DH was assessed using the Schiff Sensitivity Scale by applying air to the cervical area of the tooth for 1 s from a distance of 1 cm. A total of 300 individuals completed the Turkish DHEQ-15 in the waiting room. Subsequently, 30 randomly selected individuals with DH completed the questionnaire again after 7-10 days to assess test-retest reliability. Participants provided an overall oral health rating assessment on a 6-point scale. The reliability of the DHEQ-15 was assessed using internal consistency and test-retest methods. Exploratory Factor Analysis (EFA) identified its domains, while construct validity was evaluated through cross-cultural (Confirmatory Factor Analysis- CFA), discriminative (Mann-Whitney test) and convergent (Spearman correlation) validity.
resultsThe demographic characteristics of the sample included 137 men and 163 women, with an average age of 36. The Turkish DHEQ-15 demonstrated excellent internal consistency (α = 0.970) and outstanding test-retest reliability (r = 0.920, p < 0.001), indicating an excellent correlation. Confirmatory factor analysis confirmed the unidimensional scale structure of the Turkish DHEQ-15 (p = 0.000). A statistically significant negative correlation was found between the DHEQ-15 score and the overall oral health rating assessment (p < 0.05). Participants with DH had a significantly higher DHEQ-15 score compared to those without DH (p < 0.001).
conclusionsThis study provides evidence supporting the cross-cultural validity and reliability of the Turkish DHEQ-15.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.